Structure-Based Design of a Cyclic Peptide Inhibitor of the SARS-CoV-2 Main Protease
A. G. Kreutzer, M. Krumberger, C. M. T. Parrocha, M. A. Morris, G. Guaglianone, J. S. Nowick
This paper designs and evaluates a cyclic peptide inhibitor of SARS-CoV-2 main protease, showing in vitro activity and low toxicity to human cells.
bioRxiv · Aug 3, 2020Biochemistry